These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11450899)

  • 21. Pityriasis rosea in a patient with Behçet's disease treated with interferon alpha 2A.
    Durusoy C; Alpsoy E; Yilmaz E
    J Dermatol; 1999 Apr; 26(4):225-8. PubMed ID: 10343467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Case of Neuro-Behcet's Disease Presenting with Central Neurogenic Hyperventilation.
    Alkhachroum AM; Saeed S; Kaur J; Shams T; DeGeorgia MA
    Am J Case Rep; 2016 Mar; 17():154-9. PubMed ID: 26965646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease.
    Onal S; Kazokoglu H; Direskeneli H; Yavuz S
    Am J Ophthalmol; 2009 Jun; 147(6):1109-10; author reply 1110. PubMed ID: 19463552
    [No Abstract]   [Full Text] [Related]  

  • 24. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuro-Behçet disease presented with pachymeningitis in a child.
    Alkan G; Kartal A; Emiroğlu M; Paksoy Y
    Arch Argent Pediatr; 2019 Dec; 117(6):e644-e647. PubMed ID: 31758902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.
    Stübiger N; Besch D; Deuter CM; Zierhut M; Kötter I
    Adv Exp Med Biol; 2003; 528():529-32. PubMed ID: 12918757
    [No Abstract]   [Full Text] [Related]  

  • 27. [Manifestation of neuro-Behçet disease in cyclosporin A therapy].
    Meusser S; Eger G; Anders M; Burkhardt H; Kalden JR
    Z Rheumatol; 1997; 56(1):31-9. PubMed ID: 9173749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of interferon-alfa therapy in patients with Behçet uveitis.
    Tugal-Tutkun I; Güney-Tefekli E; Urgancioglu M
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1692-5. PubMed ID: 16673135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuro-Behçet is a rare disease but should be considered in all kinds of neurological findings, even in childhood.
    Tütüncü Toker R; Bodur M; Bican Demir A; Okan MS
    Clin Exp Rheumatol; 2022 Sep; 40(8):1588-1592. PubMed ID: 35894070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of interferon-alpha 2b in Behçet's disease.
    Durand JM; Kaplanski G; Telle H; Soubeyrand J; Paulo F
    Arthritis Rheum; 1993 Jul; 36(7):1025-6. PubMed ID: 8318030
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
    Jabs DA; Rosenbaum JT
    Am J Ophthalmol; 2001 May; 131(5):679. PubMed ID: 11354352
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.
    Wechsler B; Bodaghi B; Huong DL; Fardeau C; Amoura Z; Cassoux N; Piette JC; LeHoang P
    Ocul Immunol Inflamm; 2000 Dec; 8(4):293-301. PubMed ID: 11262659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuro-Behçet disease and magnetic resonance imaging.
    Tashiro K; Fujiki N; Moriwaka F; Yamada T; Ito K; Maruo Y
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):273-6. PubMed ID: 3437615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
    Kötter I; Zierhut M; Eckstein A; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Kanz L; Stübiger N
    Adv Exp Med Biol; 2003; 528():521-3. PubMed ID: 12918755
    [No Abstract]   [Full Text] [Related]  

  • 35. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
    Krause L; Altenburg A; Pleyer U; Köhler AK; Zouboulis CC; Foerster MH
    J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic modalities of a Behçet uveitis].
    Boca T; Rigo S
    Rev Med Liege; 2024 Jan; 79(1):48-53. PubMed ID: 38223970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
    Al Sawaf A; Berger JR
    Mult Scler Relat Disord; 2015 Sep; 4(5):395-399. PubMed ID: 26346785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuro-Behçet: MR study of a group of patients].
    Ramos C; Sá G; Tedim Cruz V; Lopes A; Xavier J; Cruz R
    Acta Med Port; 2006; 19(6):494-8. PubMed ID: 17583610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuro-Behçet: differential diagnosis of recurrent meningitis.
    Fonseca Cardoso A; Rocha-Filho PA; Melo Correa-Lima AR
    Rev Med Chil; 2013 Jan; 141(1):114-8. PubMed ID: 23732423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuro-Behçet disease. A review.
    Borhani Haghighi A; Pourmand R; Nikseresht AR
    Neurologist; 2005 Mar; 11(2):80-9. PubMed ID: 15733330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.